Healthcare -
Biotechnology - NASDAQ - US
$ 70.925
-0.33 %
$ 13.5 B
Market Cap
32.09
P/E
Price Target
Average
37.67%
Revenue Forecast
Estimate
9.75%
EBIT
Estimate
--52.54%
Net Income
Estimate
32.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BioMarin Pharmaceutical Inc.
Wall Street analysts predict an average 1-year price target for BMRN of $97.6 , with forecasts ranging from
a
low of
$65 to a high of $122 .
BMRN Lowest Price Target
Wall Street Target
65 USD
-8.35%
BMRN Average Price Target
Wall Street Target
97.6 USD
37.67%
BMRN Highest Price Target
Wall Street Target
122 USD
72.01%
REVENUE FORECAST
Revenue Forecast Chart BMRN
EBIT FORECAST
EBIT Forecast Chart BMRN
NET INCOME FORECAST
Net Income Chart BMRN